267 related articles for article (PubMed ID: 9021543)
1. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
Marais D; Rose RC; Williamson AL
J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
[TBL] [Abstract][Full Text] [Related]
2. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
[TBL] [Abstract][Full Text] [Related]
3. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
4. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
6. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
Matsumoto K; Yasugi T; Oki A; Fujii T; Nagata C; Sekiya S; Hoshiai H; Taketani Y; Kanda T; Kawana T; Yoshikawa H
Cancer Lett; 2006 Jan; 231(2):309-13. PubMed ID: 16399232
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
[TBL] [Abstract][Full Text] [Related]
8. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
[TBL] [Abstract][Full Text] [Related]
9. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
Bontkes HJ; de Gruijl TD; Walboomers JM; Schiller JT; Dillner J; Helmerhorst TJ; Verheijen RH; Scheper RJ; Meijer CJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():409-417. PubMed ID: 10073701
[TBL] [Abstract][Full Text] [Related]
10. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.
Marais DJ; Best JM; Rose RC; Keating P; Soeters R; Denny L; Dehaeck CM; Nevin J; Kay P; Passmore JA; Williamson AL
J Med Virol; 2001 Sep; 65(1):149-54. PubMed ID: 11505457
[TBL] [Abstract][Full Text] [Related]
11. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
[TBL] [Abstract][Full Text] [Related]
12. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
[TBL] [Abstract][Full Text] [Related]
13. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
Luxton JC; Rose RC; Coletart T; Wilson P; Shepherd PS
J Gen Virol; 1997 Apr; 78 ( Pt 4)():917-23. PubMed ID: 9129666
[TBL] [Abstract][Full Text] [Related]
14. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
[TBL] [Abstract][Full Text] [Related]
15. Association of antibody to E2 protein of human papillomavirus and p16
Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
[No Abstract] [Full Text] [Related]
17. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
18. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Strickler HD; Schiffman MH; Eklund C; Glass AG; Scott DR; Sherman ME; Wacholder S; Kurman RJ; Manos MM; Schiller JT; Dillner J
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):183-8. PubMed ID: 9138661
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
Sasagawa T; Yamazaki H; Dong YZ; Satake S; Tateno M; Inoue M
Int J Cancer; 1998 Feb; 75(4):529-35. PubMed ID: 9466652
[TBL] [Abstract][Full Text] [Related]
20. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
Elfgren K; Bistoletti P; Dillner L; Walboomers JM; Meijer CJ; Dillner J
Am J Obstet Gynecol; 1996 Mar; 174(3):937-42. PubMed ID: 8633673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
